ResearcherKansai Medical UniversityNo recent work listed
Yuki Hashimoto
Matched on ORCID iD 0000-0002-8070-9751; OpenAlex author ID A5046234985. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2017: 1 paper · 2018: none · 2019: 1 paper
Papers 2
- Adipophilin expression is an indicator of poor prognosis in patients with pancreatic ductal adenocarcinoma: An immunohistochemical analysis. Co-author DOI 10.1016/j.pan.2019.03.001↗
- Survival benefit of intravenous and intraperitoneal paclitaxel with S-1 in pancreatic ductal adenocarcinoma patients with peritoneal metastasis: a retrospectiv… Co-author DOI 10.1002/jhbp.447↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- So Yamaki · 2 shared papers, 2017–2019 · strength 0.15
- Paper Adipophilin expression is an indicator of poor prognosis in patients with pancreatic ductal adenocarcinoma: An immunohi… DOI 10.1016/j.pan.2019.03.001↗
- Paper Survival benefit of intravenous and intraperitoneal paclitaxel with S-1 in pancreatic ductal adenocarcinoma patients wi… DOI 10.1002/jhbp.447↗
- Hiroaki Yanagimoto · 2 shared papers, 2017–2019 · strength 0.15
- Paper Adipophilin expression is an indicator of poor prognosis in patients with pancreatic ductal adenocarcinoma: An immunohi… DOI 10.1016/j.pan.2019.03.001↗
- Paper Survival benefit of intravenous and intraperitoneal paclitaxel with S-1 in pancreatic ductal adenocarcinoma patients wi… DOI 10.1002/jhbp.447↗
- Sohei Satoi · 2 shared papers, 2017–2019 · strength 0.15
- Paper Adipophilin expression is an indicator of poor prognosis in patients with pancreatic ductal adenocarcinoma: An immunohi… DOI 10.1016/j.pan.2019.03.001↗
- Paper Survival benefit of intravenous and intraperitoneal paclitaxel with S-1 in pancreatic ductal adenocarcinoma patients wi… DOI 10.1002/jhbp.447↗
- Satoshi Hirooka · 2 shared papers, 2017–2019 · strength 0.15
- Paper Adipophilin expression is an indicator of poor prognosis in patients with pancreatic ductal adenocarcinoma: An immunohi… DOI 10.1016/j.pan.2019.03.001↗
- Paper Survival benefit of intravenous and intraperitoneal paclitaxel with S-1 in pancreatic ductal adenocarcinoma patients wi… DOI 10.1002/jhbp.447↗
- Tomohisa Yamamoto · 2 shared papers, 2017–2019 · strength 0.15
- Paper Adipophilin expression is an indicator of poor prognosis in patients with pancreatic ductal adenocarcinoma: An immunohi… DOI 10.1016/j.pan.2019.03.001↗
- Paper Survival benefit of intravenous and intraperitoneal paclitaxel with S-1 in pancreatic ductal adenocarcinoma patients wi… DOI 10.1002/jhbp.447↗
- Hironori Ryota · 1 shared paper, 2019 · strength 0.09
- Masanori Kon · 1 shared paper, 2017 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.